| Literature DB >> 34738046 |
Hannah J Vaughan1, Jordan J Green1,2.
Abstract
There is great interest in developing gene therapies for many disease indications, including cancer. However, successful delivery of nucleic acids to tumor cells is a major challenge, and in vivo efficacy is difficult to predict. Cancer theranostics is an approach combining anti-tumor therapy with imaging or diagnostic capabilities, with the goal of monitoring successful delivery and efficacy of a therapeutic agent in a tumor. Successful theranostics must maintain a high degree of anticancer targeting and efficacy while incorporating high-contrast imaging agents that are nontoxic and compatible with clinical imaging modalities. This review highlights recent advancements in theranostic strategies, including imaging technologies and genetic engineering approaches. Graphical Abstract.Entities:
Year: 2021 PMID: 34738046 PMCID: PMC8562678 DOI: 10.1016/j.cobme.2021.100300
Source DB: PubMed Journal: Curr Opin Biomed Eng ISSN: 2468-4511